B8F.DE实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 23:36):

Stats
今日成交量	7 000.00
平均成交量	10 755.00
市值	951 046
EPS	€-0.0500 ( 2023-11-28 )
下一个收益日期	( €0 ) 2024-06-19
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-3.34
ATR14	€0 (0.00%)

Biofrontera AG 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Biofrontera AG 财务报表

Annual	2022
营收:	€25.74M
毛利润:	€20.98M (81.52 %)
EPS:	€-0.770

FY	2022
营收:	€25.74M
毛利润:	€20.98M (81.52 %)
EPS:	€-0.770

FY	2020
营收:	€30.35M
毛利润:	€26.81M (88.35 %)
EPS:	€-0.234

FY	2019
营收:	€31.27M
毛利润:	€26.39M (84.41 %)
EPS:	€-0.156

Financial Reports:

No articles found.

Biofrontera AG

Biofrontera AG, a biopharmaceutical company, engages in the research, development, and marketing of dermatological products. Its products include Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also develops RhodoLED XL for the treatment of multiple interspersed lesions; Belixos, a modern active cosmetic product for irritated and sensitive skin; and Xepi for the treatment of antibiotic-resistant bacteria. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.